Detalles de la búsqueda
1.
JYNNEOS vaccine safety surveillance during the 2022 mpox outbreak using the Vaccine Adverse Event Reporting System (VAERS) and v-safe, United States, 2022-2023.
Sex Transm Dis
; 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647241
2.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
MMWR Morb Mortal Wkly Rep
; 72(2): 39-43, 2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634021
3.
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023.
MMWR Morb Mortal Wkly Rep
; 72(23): 621-626, 2023 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289661
4.
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
Ann Intern Med
; 175(4): 513-522, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35038274
5.
Expected Rates of Select Adverse Events After Immunization for Coronavirus Disease 2019 Vaccine Safety Monitoring.
J Infect Dis
; 225(9): 1569-1574, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34958099
6.
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years - United States, March 29, 2022-July 10, 2022.
MMWR Morb Mortal Wkly Rep
; 71(30): 971-976, 2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35900925
7.
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(33): 1047-1051, 2022 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980875
8.
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
MMWR Morb Mortal Wkly Rep
; 71(44): 1401-1406, 2022 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36327162
9.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
MMWR Morb Mortal Wkly Rep
; 71(7): 249-254, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35176008
10.
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 347-351, 2022 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35239637
11.
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022.
MMWR Morb Mortal Wkly Rep
; 71(28): 899-903, 2022 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834416
12.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
MMWR Morb Mortal Wkly Rep
; 71(3): 90-95, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051137
13.
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination - PCORnet, United States, January 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(14): 517-523, 2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35389977
14.
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
JAMA
; 327(4): 331-340, 2022 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35076665
15.
Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians.
J Gen Intern Med
; 36(7): 2030-2038, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33483822
16.
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
MMWR Morb Mortal Wkly Rep
; 70(39): 1379-1384, 2021 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34591835
17.
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 685-688, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956781
18.
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
MMWR Morb Mortal Wkly Rep
; 70(5152): 1755-1760, 2021 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968370
19.
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 680-684, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956784
20.
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
MMWR Morb Mortal Wkly Rep
; 70(31): 1053-1058, 2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351881